ANL
Adlai Nortye Ltd.
$10.18
-0.59 (-5.48%)
At close · Jul 8
Market Cap
$655.57M
Shares
58,734,604
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$10.18
Open$10.42
Day$9.83–10.75
52W$0.88–17.25
Avg vol 30d153K
Short int3.3M · 5.7% float · 26.2d
Short vol64%
DataSep 2023–Jul 2026
Equibles Rating
blended score · not investment advice
Overall
Neutral
SellHoldBuy
Technical
Buy
Momentum
Very Strong
Sentiment
Neutral
Fundamentals
Limited
Quant / Vol
Very High
Market backdrop
VIX 16.9 · calm
Equity put/call 0.86
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+54%
above
Price vs 50-day avg
−13%
below
RSI (14)
46
neutral
MACD trend
Positive
52-week position
57%
mid-range
Momentum
relative strength
1-month return
0%
trailing
6-month return
+517%
trailing
YTD return
+617%
this year
Relative strength
+510%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $12 › 200d $7 — 50d above 200d
Institutional flow
Accumulating
+420% holders QoQ · +22 funds added
Insider flow
Distributing
Net -$132 over 90 days · 100% sells
Short interest
Rising
5.67% of float · ▲ +3.8% MoM · 26.2 days cover
Volume signal
Reversal watch
High volume on a down day — possible exhaustion
Institution breadth
Multi-yr high
26 holders — near 3-yr high, broad support
Squeeze score
63
elevated · 0–100
Fundamentals
Not enough data for a confident read.
Quant / Vol
risk profile
Volatility
147%
annualized · 1-yr
Max drawdown
−51%
past year
ATR
13.5%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+54%
Bullish
Price vs 50-day avg
−13%
Bearish
RSI (14)
46
Neutral
MACD trend
Positive
Bullish
52-week position
57%
Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50d $12 › 200d $7 — 50d above 200d
Institutional flow
Accumulating
+420% holders QoQ · +22 funds added
Insider flow
Distributing
Net -$132 over 90 days · 100% sells
Short interest
Rising
5.67% of float · ▲ +3.8% MoM · 26.2 days cover
Volume signal
Reversal watch
High volume on a down day — possible exhaustion
Institution breadth
Multi-yr high
26 holders — near 3-yr high, broad support
Price context
position in its 52-week range
52-wk low $1
Now $10 · 57%
52-wk high $17
vs 200-day avg +54%
vs 50-day avg -13%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
ANL
this stock
Adlai Nortye Ltd.
|
$655.57M | +616.9% | — | — | 5.7% |
|
ONC
BeOne Medicines Ltd.
|
$436.30B | -0.6% | +22179.2% | 887.9 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$126.50B | +9.9% | +46.2% | 29.6 | 1.8% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$69.50B | -14.0% | +20.8% | 16.2 | 3.2% |
|
ARGX
Argenx SE
|
$57.20B | +8.8% | — | — | 2.4% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| ANL | -11.5% | -0.5% | +517.0% | -11.5% | +616.9% |
| SPY | -0.2% | +0.8% | +7.4% | -0.2% | +9.3% |
| vs SPY | -11.3% | -1.3% | +509.5% | -11.3% | +607.6% |